1772 related articles for article (PubMed ID: 25835982)
21. Hepatic histology in obese patients undergoing bariatric surgery.
Machado M; Marques-Vidal P; Cortez-Pinto H
J Hepatol; 2006 Oct; 45(4):600-6. PubMed ID: 16899321
[TBL] [Abstract][Full Text] [Related]
22. Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease.
López IC; Aroca FG; Bernal MDF; Mompeán JAL; Bernal ÁB; Martínez AMH; Barba EM; Velasco JAN; Paricio PP
Obes Surg; 2017 Sep; 27(9):2347-2353. PubMed ID: 28229316
[TBL] [Abstract][Full Text] [Related]
23. Impact of Diabetes Mellitus and Insulin on Nonalcoholic Fatty Liver Disease in the Morbidly Obese.
Strey CBM; de Carli LA; Fantinelli M; Gobbato SS; Bassols GF; Losekann A; Coral GP
Ann Hepatol; 2018 July - August ,; 17(4):585-591. PubMed ID: 29893699
[TBL] [Abstract][Full Text] [Related]
24. Considerations for bariatric surgery in patients with cirrhosis.
Goh GB; Schauer PR; McCullough AJ
World J Gastroenterol; 2018 Jul; 24(28):3112-3119. PubMed ID: 30065557
[TBL] [Abstract][Full Text] [Related]
25. HSCRP as surrogate marker in predicting long term effect of bariatric surgery on resolution of non-alcoholic steatohepatitis.
Tan CH; Al-Kalifah N; Lee WJ; Ser KH; Lee YC; Chen JC
Asian J Surg; 2019 Jan; 42(1):203-208. PubMed ID: 29804707
[TBL] [Abstract][Full Text] [Related]
26. Compare the Combined Diagnostic Accuracy of Transient Elastography and Visual Liver Score in Assessing Non-Alcoholic Fatty Liver Disease (NAFLD) and Compare it with Liver Biopsy in Morbidly Obese Patients Undergoing Bariatric Surgery: An Observational Study.
Sharma D; Anand G; Meena S; Bhardwaj V
Obes Surg; 2024 Apr; 34(4):1247-1256. PubMed ID: 38411879
[TBL] [Abstract][Full Text] [Related]
27. Nonalcoholic fatty liver disease in patients with different baseline glucose status undergoing bariatric surgery: analysis of intraoperative liver biopsies and literature review.
Souto KP; Meinhardt NG; Ramos MJ; Ulbrich-Kulkzynski JM; Stein AT; Damin DC
Surg Obes Relat Dis; 2018 Jan; 14(1):66-73. PubMed ID: 29104004
[TBL] [Abstract][Full Text] [Related]
28. Intraoperative Liver Biopsy During Adolescent Bariatric Surgery: Is It Really Necessary?
Jones RE; Yeh AM; Kambham N; El Haija MA; Pratt J; Bruzoni M
Obes Surg; 2020 Jan; 30(1):69-76. PubMed ID: 31446562
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity.
Meneses D; Olveira A; Corripio R; Méndez MDC; Romero M; Calvo-Viñuelas I; Herranz L; Vicent D; de-Cos-Blanco AI
Endocrinol Diabetes Nutr (Engl Ed); 2022 Mar; 69(3):178-188. PubMed ID: 35396116
[TBL] [Abstract][Full Text] [Related]
30. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
[TBL] [Abstract][Full Text] [Related]
31. Identification of Predictors of Non-alcoholic Steatohepatitis and Its Severity in Individuals Undergoing Bariatric Surgery.
Ayres ABS; Carneiro CRG; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
Obes Surg; 2024 Feb; 34(2):456-466. PubMed ID: 38097891
[TBL] [Abstract][Full Text] [Related]
32. The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods.
Soresi M; Cabibi D; Giglio RV; Martorana S; Guercio G; Porcasi R; Terranova A; Lazzaro LA; Emma MR; Augello G; Cervello M; Pantuso G; Montalto G; Giannitrapani L
Biomed Res Int; 2020; 2020():5023157. PubMed ID: 32420347
[TBL] [Abstract][Full Text] [Related]
33. The predictive role of parathyroid hormone for non-alcoholic fatty liver disease based on invasive and non-invasive findings in candidates of bariatric surgery.
Jamialahmadi T; Nematy M; Jangjoo A; Goshayeshi L; Abdalla MA; Akhlaghi S; Sathyapalan T; Sahebkar A
Eat Weight Disord; 2022 Mar; 27(2):693-700. PubMed ID: 33999371
[TBL] [Abstract][Full Text] [Related]
34. Patients with clinically metabolically healthy obesity are not necessarily healthy subclinically: further support for bariatric surgery in patients without metabolic disease?
Haskins IN; Chang J; Nor Hanipah Z; Singh T; Mehta N; McCullough AJ; Brethauer SA; Schauer PR; Aminian A
Surg Obes Relat Dis; 2018 Mar; 14(3):342-346. PubMed ID: 29519663
[TBL] [Abstract][Full Text] [Related]
35. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
[TBL] [Abstract][Full Text] [Related]
36. The spectrum of non alcoholic fatty liver disease in morbidly obese patients: prevalence and associate risk factors.
Feijó SG; Lima JM; Oliveira MA; Patrocínio RM; Moura-Junior LG; Campos AB; Lima JW; Braga LL
Acta Cir Bras; 2013 Nov; 28(11):788-93. PubMed ID: 24316747
[TBL] [Abstract][Full Text] [Related]
37. Histological grading evaluation of non-alcoholic fatty liver disease after bariatric surgery: a retrospective and longitudinal observational cohort study.
Chaim FDM; Pascoal LB; Chaim FHM; Palma BB; Damázio TA; da Costa LBE; Carvalho R; Cazzo E; Gestic MA; Utrini MP; Milanski M; Chaim EA; Leal RF
Sci Rep; 2020 May; 10(1):8496. PubMed ID: 32444690
[TBL] [Abstract][Full Text] [Related]
38. Risk factors and prevalence of liver disease in review of 2557 routine liver biopsies performed during bariatric surgery.
Udelsman BV; Corey KE; Lindvall C; Gee DW; Meireles OR; Hutter MM; Chang DC; Witkowski ER
Surg Obes Relat Dis; 2019 Jun; 15(6):843-849. PubMed ID: 31014948
[TBL] [Abstract][Full Text] [Related]
39. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
Kazankov K; Tordjman J; Møller HJ; Vilstrup H; Poitou C; Bedossa P; Bouillot JL; Clement K; Grønbaek H
J Gastroenterol Hepatol; 2015 Aug; 30(8):1293-300. PubMed ID: 25772748
[TBL] [Abstract][Full Text] [Related]
40. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?
Blond E; Disse E; Cuerq C; Drai J; Valette PJ; Laville M; Thivolet C; Simon C; Caussy C
Diabetologia; 2017 Jul; 60(7):1218-1222. PubMed ID: 28352941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
